CD4 and colitis: Finally, B. fragilis can both prevent and cure colitis in mouse models by releasing PSA in outer membrane vesicles, stimulating plasmacytoid dendritic cells to act in concert with CD4+ T cells and conferring immunoprotection (Round and Mazmanian, 2010; Shen et al., 2012; Dasgupta et al., 2014).